- US-listed companies
- Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc.ORIC
Market cap
$608.79M
P/E ratio
Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Cash and cash equivalents | 78 | 226 | 67 |
Short-term investments | - | 11 | 139 |
Prepaid expenses and other current assets | 3 | 4 | 4 |
Total current assets | 297 | 241 | 210 |
Long-term investments | - | 43 | 22 |
Property and equipment, net | 2 | 2 | 3 |
Other assets | 0 | 12 | 12 |
Total assets | 299 | 299 | 247 |
Accounts payable | 1 | 2 | 1 |
Accrued liabilities | 8 | 13 | 14 |
Total current liabilities | 9 | 15 | 15 |
Other long-term liabilities | - | 11 | 9 |
Total liabilities | 9 | 26 | 25 |
Common Stock, Value, Issued | 0 | 0 | 0 |
Additional paid-in capital | 456 | 518 | 558 |
Accumulated deficit | -166 | -245 | -334 |
Accumulated other comprehensive loss | -0 | -0 | -1 |
Total stockholders' equity | 290 | 273 | 222 |
Total liabilities and stockholders' equity | 299 | 299 | 247 |